Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)

v3.10.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Consolidated Statements of Operations        
Revenue $ 412   $ 1,157 $ 1,101
Operating expenses:        
Research and development 12,856 $ 10,447 35,054 30,116
General and administrative 3,876 3,593 11,792 10,151
Total operating expenses 16,732 14,040 46,846 40,267
Loss from operations (16,320) (14,040) (45,689) (39,166)
Other income, net 583 215 1,442 458
Net loss $ (15,737) $ (13,825) $ (44,247) $ (38,708)
Net loss per share - basic and diluted $ (0.47) $ (0.53) $ (1.37) $ (1.54)
Weighted-average number of common shares used in net loss per share - basic and diluted 33,653,479 26,259,216 32,306,261 25,100,278